Advertise on podcast: The LDN Radio Show About Low Dose Naltrexone

Explore the latest advancements in Low Dose Naltrexone (LDN) research with the LDN Research Trust Radio Show. Hosted by Linda Elsegood, this episode delves into viral infections, Long COVID, mold toxicity, cancer, and longevity. Discover insights from featured books and learn about ongoing research initiatives, including a survey on LDN and anti-aging. Connect with the Trust for further information and potential collaborations by visiting our website at www.LDNResearchTrust.org and our LDN Community at www.LDNRTcommunity.org.

Join host Linda Elsegood and Crystal Matte, PharmD on the LDN Radio as they explore the transformative power of Low-Dose Naltrexone (LDN). Discover how LDN is revolutionizing treatment for various chronic conditions, from autoimmune diseases and inflammation to pain management and hormonal imbalances. Hear inspiring patient testimonials and gain insights from pharmacists dedicated to this innovative therapy.

Join host Linda Elsegood on the LDN Radio Show as she interviews Rachel, a woman with over 25 years of experience living with multiple sclerosis. Rachel shares her transformative journey with Low Dose Naltrexone (LDN), detailing significant symptom relief and medication reduction. Discover how LDN has positively impacted her life, addressing issues like double vision, spasticity, and incontinence.

This LDN Radio Show episode features Joyce Risa Kleinman sharing her daughter Jenni’s inspiring journey with ALS. Jenni, a naturopathic physician, found significant relief and extended quality of life through low-dose naltrexone (LDN) after her diagnosis. The discussion explores the challenges of LDN adoption in medicine and highlights Jenni’s remarkable resilience and advocacy.

Explore a personalized approach to Low-Dose Naltrexone (LDN) with Dr. JJ Allen on the LDN Radio Show. Discover his journey from engineering to pharmacy, advocating for foundational health, lifestyle changes, and evidence-based nutraceuticals. Learn about optimizing key nutrients and the nuanced titration of LDN for autoimmune conditions and long COVID.

This episode of the LDN Radio Show features Deborah sharing her journey with peripheral neuropathy and her positive experience using low-dose naltrexone (LDN). Host Linda Elsegood also discusses her own experiences with chronic pain conditions and the benefits of LDN. The conversation touches upon gut health, the FODMAP diet, and the challenges of accessing and raising awareness for LDN treatments.

This professional discussion explores the innovative microdosing protocol for Low Dose Naltrexone (LDN) developed by Dr. Norman Marcus. The conversation highlights its effectiveness in managing autoimmune diseases, cancers, and particularly Mast Cell Activation Syndrome (MCAS). Learn about the challenges and advancements in LDN therapy and its growing applications.

Join Linda Elsegood and Dr. Marina Straseck-Sury on the LDN Radio Show as they explore women's health, fertility, and lifestyle impacts. Dr. Straseck-Sury, an experienced OBGYN, shares her journey and insights into natural fertility solutions. Discover innovative therapies and essential health topics discussed in her new book, now available for pre-order on Amazon

Dr. Yusaf (PJ) Saleeby shares insights from his practice in 2025 regarding Low Dose Naltrexone (LDN). He discusses patient sensitivity, optimal starting doses, and LDN's efficacy for various conditions including Lyme, cancer, and autoimmune diseases. The conversation also delves into Mast Cell Activation Syndrome (MCAS) and the critical role of informed clinicians in its management.

Low dose naltrexone (LDN) offers potential benefits for various health issues. A Missie from the US shares her personal experience with LDN, highlighting her battles with chronic pain, autoimmune diseases, and a blood disorder. After initial scepticism, she notices significant health improvements, including better sleep and reduced pain. LDN helps reverse organ damage and improve her blood condition, emphasising the need for patience and openness to its benefits.

Pharmacist Dr. James Blackburn shares his journey in pharmacy and the significance of compounding. He discusses low-dose naltrexone (LDN) and its benefits for autoimmune diseases, mental health, and women's health. Insights on compounding practices, quality, and personal experiences with fertility and mental health challenges are highlighted. Dr. Blackburn emphasizes the importance of proper testing and lifestyle's impact on health, addressing the community's need for effective treatments.

DescriptionExplore the profound impact of music therapy with Professor Lee Anna Rasar on the LDN Radio Show. Discover how adapted songs aid anger management, how harmonica playing enhances respiratory function, and how melodic intonation therapy assists stroke patients. Learn about music's role in sleep induction, dementia care, and Parkinson's gait training, showcasing its neuroscience-based approach. Book for the Live Zoom webinar, $20 including the recording With Lee Anna Rasar, Professor of Music Education/Therapy, titled “Dancing in the Rain: Music to Complement LDN.” for medical professionals and patients 28th April at 11:00 a.m. Central Time (5:00 p.m. UK Time). 1-hour presentation followed by a 1-hour live Q&A register at https://linktr.ee/ldnrt

Low dose naltrexone (LDN) shows promise in treating autoimmune diseases and cancers. Dr. Stephanie Werner shares insights on LDN's effectiveness in managing inflammation and enhancing patient outcomes, particularly in women's health issues like polycystic ovary syndrome and pregnancy challenges. The importance of diet and avoiding inflammatory foods is discussed, along with personal responsibility in healthcare and LDN's potential in managing chronic conditions.

Low-dose naltrexone (LDN) is highlighted as a supportive treatment in oncology, enhancing other therapies rather than acting alone. It helps regulate the immune system, calms microglia, and alleviates symptoms like pain and fatigue. LDN's low toxicity and potential to improve quality of life are emphasized, along with its evolving role in cancer therapies and immune modulation.

Low-dose naltrexone (LDN) is discussed as a treatment for chronic illnesses, focusing on its effectiveness and dosing protocols. Experts highlight the importance of collaboration among healthcare providers and the need for more research and awareness. They address misconceptions, potential insurance coverage, and share patient experiences, emphasizing personalized care in managing chronic conditions. The show invites further inquiries from the audience.